Hofheinz, R., Al-Batran, S., Hochhaus, A., Jäger, E., Reichardt, V. L., Fritsch, H., . . . Munzert, G. (2010). An open-label, phase I study of the polo-like kinase-1 inhibitor, BI 2536, in patients with advanced solid tumors. Clinical cancer research, 16(18), . https://doi.org/10.1158/1078-0432.CCR-10-0318
Chicago-Zitierstil (17. Ausg.)Hofheinz, Ralf-Dieter, Salah-Eddin Al-Batran, Andreas Hochhaus, Elke Jäger, Volker L. Reichardt, Holger Fritsch, Dirk Trommeshauser, und Gerd Munzert. "An Open-label, Phase I Study of the Polo-like Kinase-1 Inhibitor, BI 2536, in Patients with Advanced Solid Tumors." Clinical Cancer Research 16, no. 18 (2010). https://doi.org/10.1158/1078-0432.CCR-10-0318.
MLA-Zitierstil (9. Ausg.)Hofheinz, Ralf-Dieter, et al. "An Open-label, Phase I Study of the Polo-like Kinase-1 Inhibitor, BI 2536, in Patients with Advanced Solid Tumors." Clinical Cancer Research, vol. 16, no. 18, 2010, https://doi.org/10.1158/1078-0432.CCR-10-0318.